Swiss Companies Invest $27 Billion in US
Analysis based on 7 articles · First reported Jun 07, 2026 · Last updated Jun 07, 2026
The significant investment by Swiss companies like Novartis and Roche into the United States is a positive for the U.S. economy, potentially boosting job creation and economic growth. However, new U.S. tariffs on Swiss goods related to forced labor could introduce some friction and uncertainty for Swiss exporters.
Swiss companies have invested $27 billion in the United States between January and April, fulfilling a pledge made as part of a preliminary tariff agreement. This agreement, reached on November 14, saw former U.S. President Donald Trump reduce punitive tariffs on Swiss goods from 39% to 15%. In return, Switzerland committed to a $200 billion investment in the U.S. over five years. Major investors include Novartis, establishing a biomedical research center and a cancer-drug facility; Roche, expanding output in North Carolina; and Life sciences industry in Switzerland, building a new factory. Other investments come from Oman Shipping Company, Pfiffner Group, and LG Electronics. Despite this, the United States recently announced new tariffs, including a 12.5% tariff on Swiss goods, citing concerns over forced labor.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard